Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the post-smtp domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/cwbk.umed.pl/public_html/wp-includes/functions.php on line 6114
The COMBO-UC trial project has been recommended for funding under Competition ABM/2022/3

The COMBO-UC trial project has been recommended for funding under Competition ABM/2022/3

We are very pleased to announce that the Project “Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head to head COMBO-UC trial” has been recommended for funding under the Competition ABM/2022/3 (Competition for non-commercial clinical trials or research experiments – head to head studies).

Our Competition proposal received 131 points, was granted funding of nearly PLN 20 million and was ranked fifth in the ranking among 49 of all evaluated Proposals.

Congratulations and thanks to the entire team that worked for this success at the stage of designing the study and preparing the Competition Application, and in particular to: Prof. Renata Talar – Wojnarowska, Dr. Adam Fabisiak, Dr. Hubert Zatorski, and on behalf of CWBK: Prof. Wojciech Fendler, Dr. Joanna Połowinczak – Przybyłek, Małgorzata Kowalczyk, Katarzyna Płoszka and Karolina Słoczyńska from the Projects Department.

More information about the Project under the tab: Our Projects

share

Last news